Back to Search
Start Over
Proof-of-concept and Randomized, Placebo-controlled Trials of an FcRn Inhibitor, Batoclimab, for Thyroid Eye Disease
- Source :
- The Journal of Clinical Endocrinology & Metabolism; December 2023, Vol. 108 Issue: 12 p3122-3134, 13p
- Publication Year :
- 2023
Details
- Language :
- English
- ISSN :
- 0021972X and 19457197
- Volume :
- 108
- Issue :
- 12
- Database :
- Supplemental Index
- Journal :
- The Journal of Clinical Endocrinology & Metabolism
- Publication Type :
- Periodical
- Accession number :
- ejs64507365
- Full Text :
- https://doi.org/10.1210/clinem/dgad381